Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

345.73
+3.441.00%
Post-market: 348.102.37+0.69%17:04 EDT
Volume:352.91K
Turnover:121.67M
Market Cap:7.71B
PE:-26.98
High:348.34
Open:340.98
Low:339.31
Close:342.29
52wk High:377.46
52wk Low:200.63
Shares:22.29M
Float Shares:11.00M
Volume Ratio:0.68
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8155
EPS(LYR):-21.9007
ROE:-36.30%
ROA:-18.31%
PB:11.07
PE(LYR):-15.79

Loading ...

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Yesterday

Madrigal Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 07

Madrigal Pharmaceuticals (MDGL) Receives a Buy from Oppenheimer

TIPRANKS
·
Aug 06

Citi Reaffirms Their Buy Rating on Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
Aug 06

Madrigal Pharmaceuticals: Strategic Growth and Market Potential Driven by Rezdiffra’s Success and Key Acquisitions

TIPRANKS
·
Aug 06

Cautious Outlook on Madrigal Pharmaceuticals: Sell Rating Amid Competitive Pressures and Valuation Concerns

TIPRANKS
·
Aug 06

Madrigal Pharmaceuticals Reports Strong Q2 2025 Results

TIPRANKS
·
Aug 06

Madrigal Pharmaceuticals Files Initial Ownership Statement for Director Daniel J. Brennan

Reuters
·
Aug 06

Madrigal Pharmaceuticals Inc : Canaccord Genuity Raises Target Price to $428 From $420

THOMSON REUTERS
·
Aug 05

Madrigal Pharmaceuticals Shares Jump 12.5% Premarket After Q2 Sales Increase

THOMSON REUTERS
·
Aug 05

Stock Track | Madrigal Pharmaceuticals Soars 10.54% Pre-market on Strong Q2 Results and Strategic Advancements

Stock Track
·
Aug 05

Earnings Flash (MDGL) Madrigal Pharmaceuticals Posts Q2 Loss of $1.90, vs. FactSet Est of $3.55 Loss

MT Newswires Live
·
Aug 05

Madrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)

TIPRANKS
·
Aug 05

Madrigal Pharmaceuticals Q2 EPS $(1.90) Beats $(3.64) Estimate, Sales $212.802M Beat $158.902M Estimate

Benzinga
·
Aug 05

BRIEF-Madrigal Pharmaceuticals Q2 EPS USD -1.9

Reuters
·
Aug 05

Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO), Madrigal Pharmaceuticals (MDGL) and AbbVie (ABBV)

TIPRANKS
·
Aug 04

Madrigal Pharmaceuticals Signs Global License Agreement

TIPRANKS
·
Jul 30

Madrigal signs up to $2 billion deal with China's CSPC to develop liver drug

Reuters
·
Jul 30

CSPC Pharmaceutical - Deal for Global Development, Manufacturing and Commercialization of Syh2086

THOMSON REUTERS
·
Jul 30